Combined Transcranial Magnetic Stimulation and Therapy for MTBI Related Headaches
Combined Nonpharmacological Therapies for MTBI-Related Headaches
Veterans Medical Research Foundation
240 participants
Jan 1, 2022
INTERVENTIONAL
Conditions
Summary
This study will assess the combined effectiveness of repetitive transcranial magnetic stimulation (rTMS) and telehealth based therapy in helping manage mild traumatic brain injury (mTBI) related headaches. The investigators hypothesize that active rTMS combined with telehealth therapy will provide marked reduction in mTBI related headaches and symptoms in comparison to their placebo counterparts.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Active rTMS will be given at the left dorsolateral prefrontal cortex with a double blind TMS coil.
Therapy will be provided on headache management.
Sham rTMS will be given at the left dorsolateral prefrontal cortex. All parameters of the treatment will appear identical to the active treatment, with only the rTMS coil used to administer the treatment flipped 180 degrees to prevent stimulation.
In the control, educational sessions on headaches will be provided.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05176392